Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
93
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Primary refractory multiple myeloma – what role for high dose melphalan?

Sergio GiraltDepartment of Medicine, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Medicine Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]
Page 2785 | Received 30 Jul 2020, Accepted 31 Jul 2020, Published online: 14 Oct 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Primary refractory multiple myeloma – what role for high dose melphalan?." Leukemia & Lymphoma, 61(12), p. 2785

Disclosure statement

No potential conflict of interest was by reported the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.